---
title: "Spruce Biosciences (SPRB.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SPRB.US/norm.md"
symbol: "SPRB.US"
name: "Spruce Biosciences"
parent: "https://longbridge.com/en/quote/SPRB.US.md"
datetime: "2026-03-13T00:06:37.635Z"
locales:
  - [en](https://longbridge.com/en/quote/SPRB.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SPRB.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SPRB.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/SPRB.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/SPRB.US/norm.md)


# Spruce Biosciences (SPRB.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -11.29 | -14.58 | -3.50 | -23.96 | -42.58 |
| ROE | -244.60% | -353.85% | -58.01% | -254.45% | -234.25% |
| Revenue | - | - | - | - | 697000.00 |
| Net income | -14.65M | -8.21M | -2.07M | -14.04M | -23.56M |
| Operating income | -3.20M | -8.23M | -2.69M | -14.49M | -24.07M |
| Gross margin | - | - | - | - | -2978.48% |
| Net margin | - | - | - | - | -3380.06% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 53.02M | 15.31M | 21.82M | 31.65M | 45.21M |
| Leverage | 1.25 | 2.84 | 1.66 | 2.07 | 1.57 |
| BVPS | 30.99 | 9.56 | 23.41 | 27.21 | 51.18 |
| Turnover | - | 0.0173 | 0.0267 | 0.0488 | 0.0659 |
| Cash & STI | 48.91M | 10.67M | 16.39M | 25.61M | 38.75M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 666000.00 | 735000.00 | 803000.00 | 869000.00 | 934000.00 |
| Net debt | -48.17M | -9.32M | -14.56M | -23.32M | -35.99M |

## Cash Flow Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -6.46M | -5.32M | -8.83M | -12.73M | -20.68M |
| Investing CF | - | - | - | - | - |
| Financing CF | 44.69M | -402000.00 | -400000.00 | -411000.00 | -625000.00 |
| Free CF | 1.53M | -2.24M | -8.57M | -7.33M | -12.63M |
| OCF coverage | -767.66% | -1312.59% | -2174.38% | -3142.47% | -5092.86% |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |